Diabetes Technology Trends: A Review of the Latest Innovations - Top-Institutions - MDSpire

Diabetes Technology Trends: A Review of the Latest Innovations

  • By

  • Erika L Lundgrin

  • Clare A Kelly

  • Natalie Bellini

  • Claudia Lewis

  • Ebne Rafi

  • Betul Hatipoglu

  • February 25, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Joslin Diabetes Center
    Joslin Diabetes Center

    Boston, MA

    Key Differentiators

    • Diabetes Research
    • Endocrinology
    • Diabetes Technology

  • #2

    Barbara Davis Center for Diabetes, University of Colorado
    Barbara Davis Center for Diabetes, University of Colorado

    Aurora, CO

    Key Differentiators

    • Pediatric and Adult Diabetes
    • Diabetes Technology

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Diabetes Technology
    • Clinical Trials

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Diabetes Technology
    • Clinical Research

  • #5

    Cincinnati Children’s Hospital Medical Center
    Cincinnati Children’s Hospital Medical Center

    Cincinnati, OH

    Key Differentiators

    • Pediatric Endocrinology
    • Diabetes Technology

Original Source(s)

Diabetes Technology Trends: A Review of the Latest Innovations

  • by Erika L Lundgrin, Clare A Kelly, Natalie Bellini, Claudia Lewis, Ebne Rafi, Betul Hatipoglu

  • February 25, 2025

Related Content

Sex differences in iron stores and associations of body iron with cardiovascular risk factors in the middle-aged general population

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

  • May 27, 2026

  • 3 min